Showing 1 – 3 of 3
Relevance | Newest | Oldest |
  • Extended Clopidogrel Monotherapy vs DAPT in Patients With Acute Coronary Syndromes at High Ischemic and Bleeding Risk: The OPT-BIRISK Randomized Clinical Trial

    Abstract Full Text
    online first
    JAMA Cardiol. 2024; 10.1001/jamacardio.2024.0534

    This randomized clinical trial evaluates clopidogrel monotherapy vs dual antiplatelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary interventions who are at high bleeding and ischemic risk.

  • Progression of Gastrointestinal Injury During Antiplatelet Therapy After Percutaneous Coronary Intervention: A Secondary Analysis of the OPT-PEACE Randomized Clinical Trial

    Abstract Full Text
    open access
    ÁñÁ«ÊÓƵ Netw Open. 2023; 6(11):e2343219. 10.1001/jamanetworkopen.2023.43219

    This secondary analysis of a randomized clinical trial assesses the association of aspirin, clopidogrel, and their combination with gastrointestinal injury progression among patients in China without high bleeding risk after percutaneous coronary intervention.

  • Growth Inhibition of Squamous Cell Carcinoma Xenografts With the Polyamine Analogue BE 4444

    Abstract Full Text
    Arch Otolaryngol Head Neck Surg. 1996; 122(9):977-981. 10.1001/archotol.1996.01890210051012